Vasodilatory edema is a frequently encountered side effect among hypertensive patients using antihypertensive drugs. Amlodipine and nifedipine are common drugs associated with vasodilatory edema. When used as monotherapy, calcium channel blockers (CCBs) are associated with a substantial risk of peripheral edema, including pedal edema, which is the most common reason for its discontinuation. 1 This is a dose-dependent adverse effect, so low-dose combination therapy is a preferred choice over high-dose monotherapy. It is less common with newer generation CCBs. 2 Reported rates of peripheral edema are dosedependent, ranging from 5% to 70% with a high dose. 3 Only 5% of pedal edema was seen with a 5 mg dose, 25% with a 10 mg dose, whereas >75% was seen with 20 mg of daily dose. 4 Ankle edema is developed mostly in women, elderly patients, those with heart failure, upright position, and those in humid environments. 5 CCB-related edema is caused by preferential arteriolar or precapillary dilation without commensurate dilation in the venous or postcapillary circulation. 3,6 The addition of an angiotensin 809005P MTXXX10.